Regencell Bioscience Holdings Ltd (RGC) — Cash Flow-to-Debt Ratio
Regencell Bioscience Holdings Ltd (RGC) has a Cash Flow-to-Debt Ratio of -1.44x as of March 2026, meaning its operating cash flow of $-2.59 Million could theoretically repay -1% of its total liabilities ($1.79 Million) in one year. See Regencell Bioscience Holdings Ltd (RGC) flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Regencell Bioscience Holdings Ltd Cash Flow-to-Debt Ratio (2003–2025)
Historical debt coverage capacity for Regencell Bioscience Holdings Ltd across 23 annual periods. For the full cash flow conversion analysis, see Regencell Bioscience Holdings Ltd cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Regencell Bioscience Holdings Ltd (2003–2025)
Year-by-year debt coverage analysis for Regencell Bioscience Holdings Ltd. Check how high is Regencell Bioscience Holdings Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -3.48x | $-3.11 Million | $895.31K | ▲ +80.9% |
| 2024 | -18.23x | $-4.00 Million | $219.51K | ▼ -132.3% |
| 2023 | -7.85x | $-4.96 Million | $632.32K | ▼ -39.8% |
| 2022 | -5.62x | $-5.27 Million | $938.03K | ▼ -3074.3% |
| 2021 | -0.18x | $-767.31K | $4.34 Million | ▲ +22.9% |
| 2020 | -0.23x | $-726.57K | $3.16 Million | ▼ -22.2% |
| 2019 | -0.19x | $-390.99K | $2.08 Million | ▼ -269.5% |
| 2018 | 0.11x | $409.90 Million | $3.70 Billion | ▼ -5.9% |
| 2017 | 0.12x | $410.50 Million | $3.48 Billion | ▼ -4.8% |
| 2016 | 0.12x | $434.40 Million | $3.51 Billion | ▲ +21.8% |
| 2015 | 0.10x | $349.10 Million | $3.43 Billion | ▲ +0.2% |
| 2014 | 0.10x | $346.90 Million | $3.42 Billion | ▼ -14.9% |
| 2013 | 0.12x | $346.60 Million | $2.91 Billion | ▼ -1.6% |
| 2012 | 0.12x | $353.10 Million | $2.91 Billion | ▲ +39.4% |
| 2011 | 0.09x | $259.40 Million | $2.98 Billion | ▼ -38.9% |
| 2010 | 0.14x | $410.80 Million | $2.88 Billion | ▲ +49.8% |
| 2009 | 0.10x | $270.00 Million | $2.84 Billion | ▼ -67.3% |
| 2008 | 0.29x | $800.00 Million | $2.75 Billion | ▲ +137.9% |
| 2007 | 0.12x | $304.00 Million | $2.49 Billion | ▼ -20.9% |
| 2006 | 0.15x | $386.00 Million | $2.50 Billion | ▼ -1.5% |
| 2005 | 0.16x | $387.00 Million | $2.47 Billion | ▼ -45.0% |
| 2004 | 0.28x | $476.00 Million | $1.67 Billion | ▼ -21.0% |
| 2003 | 0.36x | $373.00 Million | $1.04 Billion | — |